| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 641,244 | 640,083 | 629,620 | 778,533 | | Cost of Revenue | 404,176 | 408,212 | 418,396 | 512,978 | | | Gross Profit | 237,068 | 231,871 | 211,224 | 265,555 | | | Operating Expenses | | Research Development | (27,461) | 27,461 |
-
|
-
| | Selling General and Administrative | 218,881 | 163,901 | 187,730 | 219,585 | | Non Recurring |
-
|
-
|
-
| 2,965,150 | | Others | 9,570 | 9,769 | 9,592 | (67,107) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 36,078 | 30,740 | 13,902 | (2,852,073) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 124 | 54 | 34 | 76 | | Earnings Before Interest And Taxes | 36,202 | 30,794 | 13,936 | (2,851,997) | | Interest Expense | 8,768 | 8,799 | 8,950 | 9,959 | | Income Before Tax | 27,434 | 21,995 | 4,986 | (2,861,956) | | Income Tax Expense | 10,849 | 8,357 | 2,004 | (709,431) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 16,585 | 13,638 | 2,982 | (2,152,525) | | | Non-recurring Events | | Discontinued Operations | (13) | (28) | (28) | (44) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 16,572 | 13,610 | 2,954 | (2,152,569) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $16,572 | $13,610 | $2,954 | ($2,152,569) |
|
0.29% Nasdaq 0.00%
Income Statement
